Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

American Journal of Epidemiology

Volumn 172, Issue 1, 2010, Pages 47-57

  Gallicchio, Lisa ^a   Moore, Lee E ^a   Stevens, Victoria L ^a   Ahn, Jiyoung ^a   Albanes, Demetrius ^a   Hartmuller, Virginia ^a   Setiawan, V Wendy ^a   Helzlsouer, Kathy J ^a   Yang, Gong ^a   Xiang, Yong Bing ^a   Shu, Xiao Ou ^a   Snyder, Kirk ^a   Weinstein, Stephanie J ^a   Yu, Kai ^a   Zeleniuch Jacquotte, Anne ^a   Zheng, Wei ^a   Cai, Qiuyin ^a   Campbell, David S ^a   Chen, Yu ^a   Chow, Wong Ho ^a   Horst, Ronald L ^a   Kolonel, Laurence N ^a   McCullough, Marjorie L ^a   Purdue, Mark P ^a   Koenig, Karen L ^a   more..

^a Prevention and Research Center   (United States)

Author keywords

Case control studies; Cohort studies; Kidney neoplasms; Prospective studies; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

CALCIUM; CANCER; COHORT ANALYSIS; HEALTH RISK; HOMEOSTASIS; HYPOTHESIS TESTING; INHIBITION; METABOLISM; PUBLIC HEALTH; VITAMIN;

AGE; ARTICLE; BLOOD ANALYSIS; CANCER RISK; COHORT ANALYSIS; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; RACE; SEX DIFFERENCE; VITAMIN BLOOD LEVEL; ADULT; BLOOD; CASE CONTROL STUDY; CHINA; FEMALE; FINLAND; KIDNEY TUMOR; MALE; META ANALYSIS (TOPIC); PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; UNITED STATES; VITAMIN D DEFICIENCY;

ADULT; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; FEMALE; FINLAND; HUMANS; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; META-ANALYSIS AS TOPIC; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78549258326     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq115     Document Type: Article

References (39)

1. Stat bite: kidney cancer incidence, 2000-2003. J Natl Cancer Inst. 2006;98(17):1181.
2. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353(23):2477-2490.
3. Scélo G, Brennan P. The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol. 2007;4(4):205-217.
4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3): 266-281.
5. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992;13(4):719-764.
6. Horst RL, Reinhardt TA, Reddy GS. Vitamin D metabolism. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. Burlington, MA: Elsevier Academic Press; 2005:15-36.
7. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006;92(1):49-59.
8. Giovannucci E. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol. 2008;624:31-42.
9. Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2009;124(1): 250-255.
10. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41(8):1164-1169.
11. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14(8):1991-1997.
12. Mohr SB, Gorham ED, Garland CF, et al. Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? Int J Cancer. 2006;119(11):2705-2709.
13. Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer. 2006;6:264. (doi:10.1186/14712407-6-264).
14. Bosetti C, Scotti L, Maso LD, et al. Micronutrients and the risk of renal cell cancer: a case-control study from Italy. Int J Cancer. 2007;120(4):892-896.
15. Prineas RJ, Folsom AR, Zhang ZM, et al. Nutrition and other risk factors for renal cell carcinoma in postmenopausal women. Epidemiology. 1997;8(1):31-36.
16. Mellemgaard A, McLaughlin JK, Overvad K, et al. Dietary risk factors for renal cell carcinoma in Denmark. Eur J Cancer. 1996;32A(4):673-682.
17. Wilson RT, Wang J, Chinchilli V, et al. Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Am J Epidemiol. 2009;170(6):717-729.
18. Gallicchio L, Helzlsouer KJ, Chow WH, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):10-20.
19. Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30(5): 771-777.
20. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73-78.
21. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88(6): 1519-1527.
22. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451-459.
23. Chiu BC, Gapstur SM, Chow WH, et al. Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obes (Lond). 2006;30(6):940-947.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
25. Viechtbauer W. MiMa: an S-Plus/R function to fit metaanalytic mixed-, random-, and fixed-effects models [computer software and manual]. Maastricht, the Netherlands: Department of Methodology and Statistics, School for Public Health and Primary Care, Maastricht University; 2006. (http://www.wvbauer.com/ downloads.html). (Accessed February 6, 2009).
26. Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, et al. Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):36-46.
27. Zheng W, Danforth KN, Tworoger SS, et al. Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):70-80.
28. Abnet CC, Chen Y, Chow WH, et al. Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):94-106.
29. Purdue MP, Freedman DM, Gapstur SM, et al. Circulating 25-hydroxyvitamin D and risk of non-Hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):58-69.
30. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):81-93.
31. Karami S, Brennan P, Navratilova M, et al. Vitamin D pathway genes, diet, and risk of renal cell carcinoma. Int J Endocrinol. 2010;2010:879362. (doi:10.1155/2010/879362).
32. Grant WB. The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours. Eur J Cancer. 2008;44(1):12-15.
33. Grant WB, Garland CF. Evidence supporting the role of vitamin D in reducing the risk of cancer. J Intern Med. 2002; 252(2):178-179.
34. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002;94(6):1867-1875.
35. Håkansson N, Floderus B, Gustavsson P, et al. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology. 2001;12(5):552-557.
36. Karami S, Boffetta P, Stewart P, et al. Occupational sunlight exposure and risk of renal carcinoma. Cancer. 2010;116(8): 2001-2010.
37. Boffetta P, van der Hel O, Kricker A, et al. Exposure to ultraviolet radiation and risk of malignant lymphoma and multiple myeloma - a multicentre European case-control study. Int J Epidemiol. 2008;37(5):1080-1094.
38. Slattery ML, Neuhausen SL, Hoffman M, et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer. 2004;111(5):750-756.
39. John EM, Schwartz GG, Koo J, et al. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 2005;65(12):5470-5479.